Tildrakizumab versus placebo or etanercept for chronic...

  • Main
  • 2017 / 6
  • Tildrakizumab versus placebo or etanercept for chronic...

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Reich, Kristian, Papp, Kim A, Blauvelt, Andrew, Tyring, Stephen K, Sinclair, Rodney, Thaçi, Diamant, Nograles, Kristine, Mehta, Anish, Cichanowitz, Nicole, Li, Qing, Liu, Kenneth, La Rosa, Carmen, Gre
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(17)31279-5
Date:
June, 2017
File:
PDF, 740 KB
english, 2017
Conversion to is in progress
Conversion to is failed